Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: J Immunol Methods. 2014 Apr 4;409:9–20. doi: 10.1016/j.jim.2014.03.024

Table 3.

EQC results for August 2009 through August 2013 across all HVTN processing laboratories*.

Thawed PBMC Expected Range Number of
specimens
Mean % within
acceptable range
Recovery Day 1 70–130% 3420 99.0% 92.9%
Recovery Day 2 50–130% 3412 85.8% 96.2%
Viability Day 1 >80% 3420 93.9% 99.5%
Viability Day 2 >75% 3412 88.79% 99.4%
*

Includes analysis of specimens from both HIV-uninfected and infected participants.